RCUS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $24.44

Capitalizzazione di Mercato (MRQ) $3.10B

P/E (TTM) -6.3

EPS (TTM) $-3.89

Ricavi (TTM) $117M

ROE (TTM) -90.8%

Intervallo 52 sett. $14–$32

RCUS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Arcus Biosciences, Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti601 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$247M

2017-12-31 → 2025-12-31

EPS$-3.29

2019-12-31 → 2025-12-31

Flusso di cassa libero$-484M

2018-12-31 → 2025-12-31

Margine netto-393.2%

2018-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	RCUS	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-6.3media 5 anni ≈7.0	≈7.0	·	·
P/S (TTM)	26.5media 5 anni ≈10.1	≈10.1	28.1	Più costoso
P/B (MRQ)	6.7media 5 anni ≈3.3	≈3.3	4.9	Sopravvalutato
Prezzo / FCF (TTM)	-6.5media 5 anni ≈-5.0	≈-5.0	·	·
Prezzo / Flusso di cassa (TTM)	-6.5media 5 anni ≈-5.3	≈-5.3	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	4.9media 5 anni ≈3.3	≈3.3	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	RCUS	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-415.4%media 5 anni ≈-162.1%	≈-162.1%	12.5%	Debole
EBITDA Margin (Margine EBITDA)	-156.3%media 5 anni ≈-162.1%	≈-162.1%	12.5%	Debole
Margine ante imposte (TTM)	-393.2%media 5 anni ≈-146.5%	≈-146.5%	25.8%	Debole
Margine di Profitto Netto (TTM)	-393.2%media 5 anni ≈-147.9%	≈-147.9%	10.9%	Debole
ROA (TTM)	-46.0%media 5 anni ≈-19.0%	≈-19.0%	-6.2%	Debole
ROE (TTM)	-90.8%media 5 anni ≈-41.6%	≈-41.6%	-7.0%	Debole
ROIC	-61.2%media 5 anni ≈-48.2%	≈-48.2%	-20.6%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	RCUS	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		3.8media 5 anni ≈5.3	≈5.3	4.6	Bassa liquidità
Quick Ratio		1.0media 5 anni ≈0.9	≈0.9	4.4	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	RCUS	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-4.3%media 5 anni ≈88.2%	≈88.2%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	30.2%media 5 anni ≈10.8%	≈10.8%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	25.9%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	RCUS	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-3.29media 5 anni ≈$-2.72	≈$-2.72	·	·
Revenue / Share (Ricavi / Azione)	$2.30media 5 anni ≈$2.70	≈$2.70	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-4.49media 5 anni ≈$-1.58	≈$-1.58	·	·
Cash / Share (Liquidità / Azione)	$1.77media 5 anni ≈$2.00	≈$2.00	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	RCUS	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.2media 5 anni ≈0.2	≈0.2	0.2	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)		≈$411.0K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 19.8%

Prossimo report Ott 26, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 12, 2026	$-0.72	$-0.92	21.4%
31 Marzo 2026	Mag 12, 2026	$-1.02	$-0.89	-14.0%
31 Dicembre 2025		$-0.89	$-1.05	15.0%
30 Settembre 2025		$-1.27	$-1.34	5.0%
30 Giugno 2025		$0.00	$-1.15	100.0%
31 Marzo 2025		$-1.14	$-1.05	-8.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 14

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$247M	$258M	$117M	$112M	$383M	$78M	$15M	$8M	$1M
R&D Expense	$523M	$448M	$340M	$288M	$257M	$159M	$78M	$50M	$47M
SG&A Expense	$110M	$120M	$117M	$104M	$72M	$43M	$25M	$14M	$8M
Operating Expenses	$633M	$588M	$457M	$392M	$329M	$202M	$104M	$63M	$55M
Operating Income	$-386M	$-330M	$-340M	$-280M	$54M	$-124M	$-89M	$-55M	$-53M
Other Non-op	$33M	$48M	$39M	$14M	$1M	$1M	$4M	$5M	$359.0K
Pretax Income	$-353M	$-282M	$-301M	$-266M	$55M	$-123M	$-85M	·	·
Income Tax	$0	$1M	$6M	$1M	$2M	·	·	·	·
Net Income	$-353M	$-283M	$-307M	$-267M	$53M	$-123M	$-85M	$-50M	$-53M
EPS (Basic)	$-3.29	$-3.14	$-4.15	$-3.71	$0.76	$-2.24	$-1.93	·	·
EPS (Diluted)	$-3.29	$-3.14	$-4.15	$-3.71	$0.71	$-2.24	$-1.93	·	·
Shares (Basic)	107,400,000	90,100,000	74,000,000	72,000,000	69,300,000	54,800,000	43,825,991	36,357,336	3,885,508
Shares (Diluted)	107,400,000	90,100,000	74,000,000	72,000,000	74,000,000	54,800,000	43,825,991	·	·
EBITDA	$-386M	$-330M	$-340M	$-280M	$54M	$-124M	$-89M	$-55M	·

Stato Patrimoniale 23

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$222M	$150M	$127M	$206M	$148M	$173M	$58M	$71M	$98M
Short-term Investments	·	·	·	·	·	$555M	$130M	$185M	$77M
Prepaid Expense	$15M	$18M	$34M	$19M	$18M	$5M	$4M	$2M	$1M
Current Assets	$1.01B	$1.02B	$831M	$1.07B	$1.26B	$736M	$193M	$259M	$177M
PP&E (Net)	$40M	$47M	$51M	$35M	$32M	$11M	$9M	$11M	$11M
PP&E (Gross)	$90M	$88M	$82M	$58M	$50M	$25M	$21M	$19M	$15M
Accum. Depreciation	$50M	$41M	$31M	$23M	$18M	$14M	$11M	$8M	$4M
Other Non-current Assets	$63M	$73M	$106M	$114M	$116M	$6M	$872.0K	$284.0K	$2M
Total Assets	$1.14B	$1.15B	$1.09B	$1.34B	$1.59B	$772M	$203M	$275M	$190M
Accounts Payable	$42M	$18M	$17M	$20M	$10M	$16M	$5M	$3M	$4M
Accrued Liabilities	·	·	·	·	$24M	$10M	$5M	$6M	$3M
Current Liabilities	$231M	$226M	$184M	$193M	$166M	$122M	$23M	$17M	$13M
Capital Leases	$86M	$99M	$110M	$117M	$117M	$15M	·	·	·
Other Non-current Liabilities	$135M	$157M	$142M	$140M	$122M	$543.0K	$806.0K	$2M	$565.0K
Total Liabilities	·	·	·	·	$750M	$270M	$39M	$40M	$37M
Long-term Debt	$99M	$48M	$0	·	·	·	·	·	·
Common Stock	$2.12B	$1.62B	$1.31B	$1.21B	$1.12B	$6.0K	$4.0K	$4.0K	·
Paid-in Capital	·	·	·	·	$1.12B	$830M	$369M	$358M	$948.0K
Retained Earnings	$-1.49B	$-1.13B	$-849M	$-542M	$-275M	$-328M	$-205M	$-123M	$-73M
AOCI	$0	·	$0	$-7M	$-1M	$44.0K	$64.0K	$-107.0K	$-42.0K
Stockholders' Equity	$631M	$485M	$462M	$657M	$842M	$502M	$164M	$235M	$-72M
Liabilities + Equity	$1.14B	$1.15B	$1.09B	$1.34B	$1.59B	$772M	$203M	$275M	$190M
Shares Outstanding	125,300,000	92,200,000	75,500,000	72,900,000	70,800,000	63,700,000	44,200,000	43,610,823	3,278,129

Flusso di cassa 12

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$10M	$10M	$8M	$6M	$4M	$3M	$4M	$4M	$3M
Stock-based Comp	$60M	$76M	$73M	$65M	$55M	$22M	$9M	$4M	$495.0K
Operating Cash Flow	$-482M	$-170M	$-306M	$438M	$-256M	$111M	$-73M	$-43M	$-25M
CapEx	$2M	$6M	$24M	$6M	$26M	$3M	$2M	$4M	$6M
Investing Cash Flow	$66M	$-84M	$194M	$-413M	$-4M	$-434M	$59M	$-113M	$-49M
Stock Issued	$429M	$228M	$25M	$0	$220M	$434M	$1M	$4M	·
Stock Repurchased	·	·	·	·	·	·	$94.0K	$0	·
Net Stock Activity	$429M	$228M	$25M	·	$220M	$434M	$1M	·	·
Financing Cash Flow	$488M	$277M	$33M	$33M	$237M	$439M	$1M	$129M	$107M
Net Change in Cash	$72M	$23M	$-79M	$58M	$-23M	$116M	$-13M	$-27M	$33M
Taxes Paid	$0	$0	$5M	·	·	·	·	·	·
Free Cash Flow	$-484M	$-176M	$-330M	$432M	$-282M	$108M	$-75M	$-47M	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-156.3%	-127.9%	-290.6%	-250.0%	14.2%	·	-591.4%	-656.8%	·
Net Margin	-142.9%	-109.7%	-262.4%	-238.4%	13.8%	·	-564.7%	-593.7%	·
Pretax Margin	-142.9%	-109.3%	-257.3%	-237.5%	14.3%	·	·	·	·
EBITDA Margin	-156.3%	-127.9%	-290.6%	-250.0%	14.2%	·	-591.4%	-656.8%	·
ROA	-30.8%	-25.2%	-25.2%	-18.2%	4.5%	-25.2%	-35.4%	-21.3%	·
ROE	-59.8%	-53.9%	-62.5%	-39.4%	7.6%	-23.5%	-49.7%	-20.7%	·
ROIC	-61.2%	-68.3%	-75.1%	-42.8%	6.2%	·	·	·	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio		4.4	4.5	4.5	5.5	7.6	6.0	8.5	15.3	·
Quick Ratio		1.0	0.7	0.7	1.1	0.9	6.0	8.3	15.1	·

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		0.2	0.2	0.1	0.1	0.3	·	0.1	0.0	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$5.04	$5.26	$6.12	$9.01	$11.89	$7.71	$3.57	$5.28	·
Revenue / Share	$2.30	$2.86	$1.58	$1.56	$5.18	·	·	·	·
Cash Flow / Share	$-4.49	$-1.89	$-4.14	$6.08	$-3.46	·	·	·	·
Cash / Share	$1.77	$1.63	$1.68	$2.83	$2.09	$2.66	$1.26	$1.60	·
EPS (TTM)	$-3.29	$-3.14	$-4.15	$-3.71	$0.71	$-2.24	$-1.93	·	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-4.3%	120.5%	4.5%	-70.8%	391.0%	·	·	·	·
Revenue CAGR 3Y	30.2%	-12.3%	14.5%	·	·	·	·	·	·
Revenue CAGR 5Y	25.9%	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$247M	$258M	$117M	$112M	$383M	$78M	$15M	$8M	·
Net Income TTM	$-353M	$-283M	$-307M	$-267M	$53M	$-123M	$-85M	$-50M	·
Market Cap	$2.99B	$1.37B	$1.44B	$1.51B	$2.86B	$1.69B	$464M	$480M	·
P/E	-7.2	-4.7	-4.6	-5.6	57.0	-11.6	-5.2	·	·
P/S	12.1	5.3	12.3	13.5	7.5	21.7	30.9	57.4	·
P/B	4.7	2.8	3.1	2.3	3.4	3.4	2.8	2.0	·
P / Tangible Book	4.7	2.8	3.1	2.3	3.4	3.4	·	·	·
P / Cash Flow	-6.2	-8.1	-4.7	3.4	-11.2	15.2	-6.3	-11.2	·
P / FCF	-6.2	-7.8	-4.4	3.5	-10.1	15.6	-6.2	-10.3	·
Earnings Yield	-13.8%	-21.1%	-21.7%	-17.9%	1.8%	-8.6%	-19.1%	·	·

Conto Economico 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$41M	$17M	$33M	$26M	$160M	$28M	$26M	$48M	$39M	$145M	$31M	$32M	$29M	$25M	$34M	$33M
R&D Expense	$113M	$122M	$121M	$141M	$139M	$122M	$101M	$123M	$115M	$109M	$93M	$82M	$84M	$81M	$80M	$77M
SG&A Expense	$24M	$29M	$26M	$27M	$29M	$28M	$28M	$30M	$30M	$32M	$29M	$30M	$28M	$30M	$28M	$26M
Operating Expenses	$137M	$151M	$147M	$168M	$168M	$150M	$129M	$153M	$145M	$161M	$122M	$112M	$112M	$111M	$108M	$103M
Operating Income	$-96M	$-134M	$-114M	$-142M	$-8M	$-122M	$-103M	$-105M	$-106M	$-16M	$-91M	$-80M	$-83M	$-86M	$-74M	$-70M
Other Non-op	$5M	$6M	$8M	$7M	$8M	$10M	$10M	$13M	$13M	$12M	$11M	$11M	$9M	$8M	$7M	$5M
Pretax Income	$-91M	$-128M	$-106M	$-135M	$0	$-112M	$-93M	$-92M	$-93M	$-4M	$-80M	$-69M	$-74M	$-78M	$-67M	$-65M
Income Tax	$0	$0	$0	$0	$0	$0	$1M	$0	$0	$0	$1M	$2M	$1M	$2M	$0	$0
Net Income	$-91M	$-128M	$-106M	$-135M	$0	$-112M	$-94M	$-92M	$-93M	$-4M	$-81M	$-71M	$-75M	$-80M	$-67M	$-65M
EPS (Basic)	$-0.72	$-1.02	$-0.88	$-1.27	$0.00	$-1.14	$-1.07	$-1.00	$-1.02	$-0.05	$-1.08	$-0.94	$-1.04	$-1.09	$-0.93	$-0.90
EPS (Diluted)	$-0.72	$-1.02	$-0.88	$-1.27	$0.00	$-1.14	$-1.07	$-1.00	$-1.02	$-0.05	$-1.08	$-0.94	$-1.04	$-1.09	$-0.93	$-0.90
Shares (Basic)	126,100,000	125,400,000	·	106,500,000	106,100,000	98,400,000	·	91,400,000	91,100,000	86,200,000	·	74,600,000	73,200,000	73,000,000	·	72,200,000
Shares (Diluted)	126,100,000	125,400,000	·	106,500,000	106,500,000	98,400,000	·	91,400,000	91,100,000	86,200,000	·	74,600,000	73,200,000	73,000,000	·	72,200,000
EBITDA	$-96M	$-134M	·	$-142M	$-8M	$-122M	·	$-105M	$-106M	$-16M	·	$-80M	$-83M	$-86M	·	$-69M

Stato Patrimoniale 22

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$150M	$201M	$222M	$238M	$248M	$192M	$150M	$201M	$156M	$185M	·	$184M	$230M	$238M	·	$218M
Prepaid Expense	$18M	$19M	$15M	$15M	$20M	$19M	$18M	$22M	$25M	$34M	·	$31M	$22M	$28M	·	$22M
Current Assets	$756M	$844M	$1.01B	$857M	$946M	$1.03B	$1.02B	$1.13B	$1.02B	$1.06B	·	$882M	$986M	$1.01B	·	$1.10B
PP&E (Net)	$36M	$38M	$40M	$42M	$44M	$46M	$47M	$48M	$49M	$51M	·	$50M	$45M	$37M	·	$34M
PP&E (Gross)	·	·	$90M	·	·	·	$88M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$50M	·	·	·	$41M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$59M	$61M	$63M	$65M	$69M	$71M	$73M	$75M	$75M	$78M	·	$108M	$109M	$112M	·	$11M
Total Assets	$924M	$997M	$1.14B	$974M	$1.07B	$1.16B	$1.15B	$1.25B	$1.19B	$1.29B	·	$1.19B	$1.22B	$1.25B	·	$1.39B
Accounts Payable	$34M	$39M	$42M	$42M	$29M	$22M	$18M	$13M	$15M	$16M	·	$17M	$12M	$28M	·	$11M
Accrued Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$21M
Current Liabilities	$198M	$209M	$231M	$235M	$210M	$192M	$226M	$215M	$199M	$204M	·	$200M	$180M	$179M	·	$177M
Capital Leases	·	·	$86M	·	·	·	$99M	·	·	·	·	·	·	·	·	$119M
Other Non-current Liabilities	$124M	$119M	$135M	$152M	$159M	$166M	$157M	$136M	$138M	$140M	·	$145M	$144M	$145M	·	$16M
Total Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$695M
Long-term Debt	$101M	$100M	$99M	$98M	$97M	$48M	$48M	$47M	·	·	·	·	·	·	·	·
Common Stock	$2.17B	$2.14B	$2.12B	$1.81B	$1.79B	$1.77B	$1.62B	$1.60B	$1.58B	$1.56B	·	$1.29B	$1.27B	$1.23B	·	$7.0K
Paid-in Capital	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$1.18B
Retained Earnings	$-1.70B	$-1.61B	$-1.49B	$-1.38B	$-1.24B	$-1.24B	$-1.13B	$-1.04B	$-946M	$-853M	·	$-768M	$-697M	$-622M	·	$-475M
AOCI	$-1M	$-1M	·	·	·	·	·	$1M	$-1M	$-1M	·	$-3M	$-4M	$-4M	·	$-10M
Stockholders' Equity	$464M	$524M	$631M	$436M	$549M	$531M	$485M	$565M	$635M	$707M	$462M	$520M	$566M	$600M	$657M	$699M
Liabilities + Equity	$924M	$997M	$1.14B	$974M	$1.07B	$1.16B	$1.15B	$1.25B	$1.19B	$1.29B	·	$1.19B	$1.22B	$1.25B	·	$1.39B
Shares Outstanding	127,000,000	125,500,000	125,300,000	107,100,000	106,400,000	105,900,000	92,200,000	91,500,000	91,300,000	90,900,000	75,500,000	74,800,000	74,500,000	73,100,000	72,900,000	72,352,380

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$2M	$3M	$2M	$2M	$3M	$3M	$2M	$2M	$3M	$3M	$1M	$2M	$2M	$1M	$2M
Stock-based Comp	$15M	$19M	$15M	$14M	$15M	$16M	$17M	$19M	$20M	$20M	$18M	$18M	$18M	$19M	$17M	$16M
Operating Cash Flow	$-119M	$-138M	$-120M	$-97M	$-133M	$-132M	$-100M	$26M	$-94M	$-2M	$-88M	$-63M	$-57M	$-98M	$-70M	$-81M
CapEx	$0	$0	$1M	$0	$0	$1M	$1M	$1M	$0	$4M	$6M	$10M	$5M	$3M	$0	$2M
Investing Cash Flow	$52M	$114M	$-182M	$79M	$137M	$32M	$51M	$-29M	$63M	$-169M	$28M	$11M	$26M	$129M	$47M	$23M
Stock Issued	$0	$0	$279M	$8M	$0	$142M	$0	$0	$0	$228M	$0	$5M	$20M	$0	$0	·
Net Stock Activity	·	$0	·	·	·	$142M	·	·	·	$228M	·	·	·	·	·	·
Financing Cash Flow	$16M	$3M	$286M	$8M	$52M	$142M	$-2M	$48M	$2M	$229M	$3M	$6M	$23M	$1M	$11M	$3M
Net Change in Cash	$-51M	$-21M	$-16M	$-10M	$56M	$42M	$-51M	$45M	$-29M	$58M	$-57M	$-46M	$-8M	$32M	$-12M	$-55M
Free Cash Flow	·	$-138M	·	·	·	$-133M	·	·	·	$-6M	·	·	·	$-101M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-234.1%	-788.2%	·	-546.1%	-5.0%	-435.7%	·	-218.8%	-271.8%	-11.0%	·	-250.0%	-286.2%	-344.0%	·	-206.7%
Net Margin	-221.9%	-752.9%	·	-519.2%	0.00%	-400.0%	·	-191.7%	-238.5%	-2.8%	·	-221.9%	-258.6%	-320.0%	·	-193.3%
Pretax Margin	-221.9%	-752.9%	·	-519.2%	0.00%	-400.0%	·	-191.7%	-238.5%	-2.8%	·	-215.6%	-255.2%	-312.0%	·	-193.3%
EBITDA Margin	-234.1%	-788.2%	·	-546.1%	-5.0%	-435.7%	·	-218.8%	-271.8%	-11.0%	·	-250.0%	-286.2%	-344.0%	·	-206.7%
ROA	-9.1%	-11.9%	·	-12.1%	0.00%	-9.2%	·	-7.5%	-7.7%	-0.31%	·	-5.5%	-5.6%	-5.7%	·	-5.8%
ROE	-18.0%	-24.3%	·	-27.0%	0.00%	-18.1%	·	-17.0%	-15.5%	-0.61%	·	-11.7%	-11.4%	-11.5%	·	-10.5%
ROIC	-20.7%	-25.6%	·	-32.6%	·	-23.0%	·	-18.6%	-16.7%	-2.3%	·	-15.8%	-14.9%	-14.7%	·	-9.9%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		3.8	4.0	·	3.6	4.5	5.4	·	5.2	5.1	5.2	·	4.4	5.5	5.7	·	6.2
Quick Ratio		0.8	1.0	·	1.0	1.2	1.0	·	0.9	0.8	0.9	·	0.9	1.3	1.3	·	1.2

Efficienza 1

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.1	0.0	·	0.0	0.0	0.1	·	0.0	0.0	0.0	·	0.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.65	$4.18	·	$4.07	$5.16	$5.01	·	$6.17	$6.96	$7.78	·	$6.95	$7.60	$8.21	·	$9.66
Revenue / Share	$0.33	$0.14	·	$0.24	$1.50	$0.28	·	$0.53	$0.43	$1.68	·	$0.43	$0.40	$0.34	·	$0.46
Cash Flow / Share	·	$-1.10	·	·	·	$-1.34	·	·	·	$-0.02	·	·	·	$-1.34	·	·
Cash / Share	$1.18	$1.60	·	$2.22	$2.33	$1.81	·	$2.20	$1.71	$2.04	·	$2.46	$3.09	$3.26	·	$3.01
EPS (TTM)	$-3.89	$-3.17	·	$-3.48	$-3.21	$-4.23	·	$-3.15	$-3.09	$-3.11	·	$-4.00	$-3.96	·	·	·

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$117M	$236M	·	$240M	$262M	$141M	·	$263M	$247M	$237M	·	$120M	$121M	$119M	·	$433M
Net Income TTM	$-460M	$-369M	·	$-341M	$-298M	$-391M	·	$-270M	$-249M	$-231M	·	$-293M	$-287M	$-279M	·	$80M
Market Cap	$3.92B	$2.71B	·	$1.46B	$866M	$831M	·	$1.40B	$1.39B	$1.72B	·	$1.34B	$1.51B	$1.33B	·	$1.89B
P/E	-7.9	-6.8	·	-3.9	-2.5	-1.9	·	-4.9	-4.9	-6.1	·	-4.5	-5.1	·	·	·
P/S	33.5	11.5	·	6.1	3.3	5.9	·	5.3	5.6	7.2	·	11.2	12.5	11.2	·	4.4
P/B	8.4	5.2	·	3.3	1.6	1.6	·	2.5	2.2	2.4	·	2.6	2.7	2.2	·	2.7
P / Tangible Book	8.4	5.2	·	3.3	1.6	1.6	·	2.5	2.2	2.4	·	2.6	2.7	2.2	·	2.7
P / Cash Flow	·	-19.6	·	·	·	-6.3	·	·	·	-858.1	·	·	·	-13.6	·	·
Earnings Yield	-12.6%	-14.7%	·	-25.6%	-39.4%	-53.9%	·	-20.6%	-20.3%	-16.5%	·	-22.3%	-19.5%	·	·	·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$247M	$258M	$117M	$112M	$383M
Margine Operativo %	-156.3%	-127.9%	-290.6%	-250.0%	14.2%
Utile netto	$-353M	$-283M	$-307M	$-267M	$53M
EPS Diluito	$-3.29	$-3.14	$-4.15	$-3.71	$0.71

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	4.4	4.5	4.5	5.5	7.6
Quick Ratio	1.0	0.7	0.7	1.1	0.9

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-484M	$-176M	$-330M	$432M	$-282M

Proprietari istituzionali (13F) 243 filer · $4.0B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 243

Valore detenuto $4.0B

Nuove posizioni 46

Posizioni chiuse 23

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
46 (+5 vs trimestre precedente)	23 (-8 vs trimestre precedente)	86 (+2 vs trimestre precedente)	64 (+4 vs trimestre precedente)	+4.3M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
GILEAD SCIENCES, INC.	$968.825.351	31.424.760	24,50%	Azioni
BlackRock, Inc.	$506.112.958	16.416.249	12,80%	Azioni
VANGUARD GROUP INC	$189.755.288	7.962.874	4,80%	Azioni
STATE STREET CORP	$185.888.992	6.029.484	4,70%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$181.756.661	5.895.448	4,60%	Azioni
MONTANOVA CAPITAL, LLC	$147.257.121	4.776.423	3,72%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$137.980.528	4.475.528	3,49%	Azioni
FMR LLC	$124.854.021	4.049.757	3,16%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$119.877.707	3.888.346	3,03%	Azioni
CITADEL ADVISORS LLC	$96.653.807	3.135.057	2,44%	Azioni
Woodline Partners LP	$92.730.412	3.007.798	2,35%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$75.507.790	2.448.749	1,91%	Azioni
Siren, L.L.C.	$74.621.857	2.420.430	1,89%	Azioni
Fisher Asset Management, LLC	$65.957.578	2.139.396	1,67%	Azioni
MARSHALL WACE, LLP	$59.967.064	1.945.088	1,52%	Azioni
SAMLYN CAPITAL, LLC	$47.699.621	1.547.182	1,21%	Azioni
DIMENSIONAL FUND ADVISORS LP	$44.221.943	1.434.320	1,12%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$43.764.202	1.419.533	1,11%	Azioni
GOLDMAN SACHS GROUP INC	$42.778.660	1.387.566	1,08%	Azioni
Soleus Capital Management, L.P.	$36.032.193	1.168.738	0,91%	Azioni
Sofinnova Investments, Inc.	$29.155.623	945.690	0,74%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$29.034.337	941.756	0,73%	Azioni
NORTHERN TRUST CORP	$28.749.685	932.523	0,73%	Azioni
Parkman Healthcare Partners LLC	$28.340.971	919.266	0,72%	Azioni
Invesco Ltd.	$26.058.533	845.233	0,66%	Azioni
BAKER BROS. ADVISORS LP	$26.045.677	844.816	0,66%	Azioni
BANK OF AMERICA CORP /DE/	$25.758.589	835.504	0,65%	Azioni
MORGAN STANLEY	$24.537.986	795.912	0,62%	Azioni
Candriam S.C.A.	$20.389.238	661.981	0,52%	Azioni
Aberdeen Group plc	$20.061.451	650.712	0,51%	Azioni
Logos Global Management LP	$20.039.500	650.000	0,51%	Azioni
TWO SIGMA INVESTMENTS, LP	$19.589.505	635.404	0,50%	Azioni
VANGUARD FIDUCIARY TRUST CO	$18.993.993	616.088	0,48%	Azioni
Bank of New York Mellon Corp	$16.740.979	543.009	0,42%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$15.787.550	512.084	0,40%	Azioni
Ikarian Capital, LLC	$15.555.555	504.559	0,39%	Azioni
Decheng Capital LLC	$14.329.137	464.779	0,36%	Azioni
DAFNA Capital Management LLC	$13.621.588	441.829	0,34%	Azioni
JPMORGAN CHASE & CO	$13.121.105	418.243	0,33%	Azioni
PRINCIPAL FINANCIAL GROUP INC	$13.052.373	423.366	0,33%	Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$11.688.000	379.100	0,30%	Azioni
UBS Group AG	$11.377.996	369.056	0,29%	Azioni
Patient Square Capital LP	$10.969.314	355.800	0,28%	Azioni
PDT Partners, LLC	$9.975.571	323.567	0,25%	Azioni
Public Sector Pension Investment Board	$9.192.149	298.156	0,23%	Azioni
FIRST TRUST ADVISORS LP	$8.368.310	271.434	0,21%	Azioni
Nuveen, LLC	$7.215.824	234.052	0,18%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$6.936.997	225.008	0,18%	Azioni
DIADEMA PARTNERS LP	$6.900.062	223.810	0,17%	Azioni
RHUMBLINE ADVISERS	$6.757.319	219.181	0,17%	Azioni

Mostra tutti i 243 proprietari istituzionali →

Attivisti e proprietari del 5%+ 3 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Gilead Sciences, Inc.	07 Agosto 2026	24,70%	Modifica	·	SEC
Terry Rosen, Ph.D. ×2 depositi	17 Dicembre 2024	·	Deposito iniziale	·	SEC
Juan Jaen, Ph.D., Anita Galeana, Juan Carlos Jaen and Anita Galeana 2000 Trust ×2 depositi	15 Ottobre 2020	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 23 insider · 12 dirigenti · 10 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Terry J Rosen	Chief Executive Officer	23 Gennaio 2026 A	2.236.409	2	$-1.203.847
Ii Robert C. Goeltz	Chief Financial Officer	11 Maggio 2026 S	84.161	6	$-855.866
Rekha Hemrajani	Chief Operating Officer and Chief Financial Officer	25 Marzo 2019 A	·	0	$0
Juan C. Jaen	President	10 Luglio 2026 S	822.240	21	$-9.219.575
Jennifer Jarrett	Chief Operating Officer	23 Gennaio 2026 A	224.024	5	$-2.171.366
Alexander Azoy	Chief Accounting Officer	21 Agosto 2026 M	39.581	6	$-395.676
Carolyn C. Tang	General Counsel	11 Giugno 2026 M	184.607	2	$-318.467
Richard Markus	Chief Medical Officer	23 Gennaio 2026 A	89.647	2	$-210.125
Nuyten Dimitry SA	Chief Medical Officer	15 Dicembre 2024 F	87.518	0	$0
William Grossman	Chief Medical Officer	17 Giugno 2021 S	20.723	0	$0
Jason Barker	VP Finance; Principal Financial and Accounting Officer	04 Giugno 2020 A	10.000	0	$0
Steven Chan	Principal Financial and Accounting Officer	16 Gennaio 2019 A	·	0	$0
Antoni Ribas	Direttore	11 Giugno 2026 A	44.300	0	$0
Nicole Lambert	Direttore	11 Giugno 2026 A	43.000	0	$0
David L. Lacey	Direttore	11 Giugno 2026 A	76.652	0	$0
Patrick Machado	Direttore	11 Giugno 2026 A	44.300	0	$0
Yasunori Kaneko	Direttore	11 Giugno 2026 A	25.700	0	$0
Kathryn E Falberg	Direttore	11 Giugno 2026 A	44.300	0	$0
Andrew J Perlman	Direttore	11 Giugno 2026 A	48.325	0	$0
Kristen Hege	Direttore	06 Giugno 2019 A	·	0	$0
David W Beier	Direttore	06 Giugno 2019 A	·	0	$0
Gilead Sciences, Inc.	Proprietario del 10%	18 Febbraio 2025 P	31.424.760	0	$0
Hadley Harbor Master Investors (Cayman) II L.P.	Proprietario del 10%	19 Marzo 2018 C	1.496.813	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 56 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IDNA · iShares Trust	2,13%	207.943 SH	11 Settembre 2026	Giornaliero
PSCH · Invesco Exchange-Traded Fund Trust …	1,25%	85.856 SH	02 Ottobre 2026	Giornaliero
BBC · ETFis Series Trust I	0,79%	13.060 NS	31 Luglio 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,76%	864.292 SH	02 Ottobre 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,62%	284.644 NS	31 Luglio 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,50%	87.676 NS	31 Luglio 2026	N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr…	0,43%	1.384 NS	31 Luglio 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,38%	61.471 SH	02 Ottobre 2026	Giornaliero
FYX · First Trust Exchange-Traded AlphaDE…	0,23%	113.180 NS	31 Luglio 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,19%	121.164 SH	19 Agosto 2026	Giornaliero
VIOG · VANGUARD ADMIRAL FUNDS	0,18%	65.077 SH	19 Agosto 2026	Giornaliero
IBB · iShares Trust	0,16%	639.708 SH	11 Settembre 2026	Giornaliero
QVMS · Invesco Exchange-Traded Fund Trust …	0,14%	13.473 SH	02 Ottobre 2026	Giornaliero
PWS · Pacer Funds Trust	0,14%	1.198 NS	31 Luglio 2026	N-PORT
VIOO · VANGUARD ADMIRAL FUNDS	0,14%	303.431 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,13%	75.323 SH	19 Agosto 2026	Giornaliero
FAD · First Trust Exchange-Traded AlphaDE…	0,13%	25.784 NS	31 Luglio 2026	N-PORT
IWO · iShares Trust	0,12%	658.371 SH	11 Settembre 2026	Giornaliero
VIOV · VANGUARD ADMIRAL FUNDS	0,11%	68.135 SH	19 Agosto 2026	Giornaliero
BKSE · BNY Mellon ETF Trust	0,11%	3.277 NS	31 Luglio 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,09%	22.969 NS	31 Luglio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,08%	88.996 SH	02 Ottobre 2026	Giornaliero
RSSL · Global X Funds	0,08%	42.828 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,08%	514.877 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,08%	2.296.266 SH	11 Settembre 2026	Giornaliero
ESML · iShares Trust	0,06%	61.466 SH	11 Settembre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,05%	273.376 NS	31 Luglio 2026	N-PORT
TECB · iShares Trust	0,04%	8.223 SH	11 Settembre 2026	Giornaliero
SMDX · Tidal Trust III	0,04%	1.986 NS	31 Luglio 2026	N-PORT
VBK · VANGUARD INDEX FUNDS	0,04%	586.542 SH	19 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	16.721 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,04%	264.113 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,04%	41.576 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.000.271 SH	19 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,03%	10.730 SH	11 Settembre 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,02%	1.011.587 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,02%	5.013 SH	11 Settembre 2026	Giornaliero
TILT · FlexShares Trust	0,01%	6.162 NS	31 Luglio 2026	N-PORT
RWJ · Invesco Exchange-Traded Fund Trust …	0,01%	5.350 SH	02 Ottobre 2026	Giornaliero
ITOT · iShares Trust	0,00%	124.162 SH	11 Settembre 2026	Giornaliero
DCOR · Dimensional ETF Trust	0,00%	3.906 NS	31 Luglio 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	12.625 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	21.339 SH	11 Settembre 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	11.946 NS	31 Luglio 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	2.340 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	2.799.235 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.495 SH	19 Agosto 2026	Giornaliero
IJR · iShares Trust	·	5.294.319 SH	10 Settembre 2026	Giornaliero
IJT · iShares Trust	·	517.549 SH	09 Settembre 2026	Giornaliero
IJS · iShares Trust	·	287.856 SH	08 Settembre 2026	Giornaliero
IWN · iShares Trust	·	185.987 SH	11 Settembre 2026	Giornaliero
XJR · iShares Trust	·	11.976 SH	31 Agosto 2026	Giornaliero
ISCB · iShares Trust	·	3.839 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	11.367 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	99.950 SH	11 Settembre 2026	Giornaliero
SMMV · iShares Trust	·	4.789 SH	01 Settembre 2026	Giornaliero

RCUS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 19 analisti COMPRA

Target mediano $43.00 +75,9%

5 26,3% Acquisto forte

10 52,6% Compra

4 21,1% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

11 analisti · 2026-09-30

Target medio $39.91 +63,3%

Ora Prezzo attuale $24.44

Basso$23.00 Media$39.91 Alto$47.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
RCUS	$2.99B	-7.2	-4.3%	-142.9%	-59.8%	·
CELC	$4.81B	-26.3	·	·	-244.3%	·
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	·
ACAD	$4.55B	11.6	11.9%	36.5%	38.1%	·
DNLI	$2.58B	-5.6	204.7%	·	-50.2%	·
ARQT	$3.58B	-223.4	91.3%	-4.3%	-9.8%	·
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	·
DYN	$3.23B	-5.6	·	·	-57.8%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

RCUS Arcus Biosciences, Inc. Common Stock